Ophthalmology in practice (@Ophthinpractice) header
Ophthalmology in practice (@Ophthinpractice) profile picture

'Ophthalmology in practice' is a quarterly clinical review-based journal that publishes articles for eye healthcare professionals

Joined September 2016
Photo by Ophthalmology in practice (@Ophthinpractice)Photo by Ophthalmology in practice (@Ophthinpractice)Photo by Ophthalmology in practice (@Ophthinpractice)Photo by Ophthalmology in practice (@Ophthinpractice)Photo by Ophthalmology in practice (@Ophthinpractice)Photo by Ophthalmology in practice (@Ophthinpractice)
The EU has approved Novartis’ #genetherapy, Luxturna, to restore vision loss in patients with a rare hereditary retinal dystrophies. This reinforces the potential of gene therapy in treating a wide-range of challenging diseases. hashtag#novartis... pharmatimes.com/news/eu_oks_…
The EU has approved Novartis’ #genetherapy, Luxturna, to restore vision loss in patients with a rare hereditary retinal dystrophies. This reinforces the potential of gene therapy in treating a wide-range of challenging diseases. #novartis pharmatimes.com/news/eu_oks_…
1
1
We could be seeing the introduction of tactile expiry date indicators in the UK that could help tackle food waste. This was originally designed for partially sighted people, however research shows that it has wider reaching benefits #eyehealth #foodlabels goo.gl/nzkAg8
1
1
Researchers have developed an exciting smart drainage device that extends the effectiveness of implants used to manage glaucoma #eye #glaucoma #medicaltechnology goo.gl/GQsDBY
@Ophthinpractice is attending @diabetespc 2018 today and tomorrow. We're enjoying all the latest updates in diabetes care. #DPC2018
It’s world diabetes day! This years theme is The Family and Diabetes. Family play an important role in the management, care, prevention and education of diabetes. Visit worlddiabetesday.org/ and get involved! #WDD2018 #diabetes @WDD
1
1
Novartis’ brolucizumab, one of the most clinically advanced single-chain antibody fragments to date, has shown promising two-year trial results for the treatments of patients with neovascular AMD #eye #AMD #Novartis goo.gl/PGSLH2
Phase II trials of Roche’s faricimab are showing potential in alleviating the compliance burden on patients with neovascular AMD, compared with current anti-VEGF monotherapies #ophthalmology #eye #AMD goo.gl/VJTGXq
1
1
It’s good to see that a high level of growth and investment is being put into the Optical Imaging Market, especially with the rise in eye-related complications with an ageing population #ophthalmology #opticalimagingtechnology #healthcare goo.gl/p4JYbF
Dry eye disease: a brighter future. Register for FREE to read the article online! Visit ophthalmologyinpractice.co.u…
Retinal vessel analysis – a modern alternative to the arteriovenous ratio. Register for FREE to read the article here ophthalmologyinpractice.co.u…
It's World Diabetes Day! Women and Diabetes – Our Right to a Healthy Future #WDD #diabetes nitter.cf/WDD/status/93037468660…
Today is World Diabetes Day! Women and Diabetes #Right to a Health #WDD youtube.com/watch?v=Ds-FK_7G…
World Diabetes Day is tomorrow! This year's theme is Women and diabetes - our right to a healthy future. Visit idf.org/our-activities/world… … and get involved! #WDD #diabetes
World Diabetes Day is on 14th November. This year's theme is Women and diabetes - our right to a healthy future. Visit idf.org/our-activities/world… and get involved! #WDD #diabetes
#KnowYourDrops Eye Drop Compliance Campaign to Achieve Medicines Optimisation in Ophthalmology nice.org.uk/sharedlearning/k…
1
Do you want to advertise in @ophthinpractice? Act fast to be in our Winter issue! For more details contact [email protected]
5
7